In addition, the combination of ADAM17 inhibition and eplerenone administration reduced cardiac apoptosis and cardiac inflammation in diabetic mice, further improving diabetes-induced cardiac dysfunction (Supplementary Figure S3). The gene discussed is ADAM17; the disease is diabetes mellitus.